Alzinova (ALZ)

Last close As at 15/08/2025

0.00 (0.00%)

Market capitalisation

SEK121m

Alzinova is a Swedish biopharmaceutical company in clinical development specializing in the treatment of Alzheimer’s disease.

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Tord Labuda

    CEO

  • Erik Kullgren

    CFO

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free